Home > Publications >Using Genome-Editing Tools to Develop a Novel In Situ Coincidence Reporter Assay for Screening ATAD3A Transcriptional Inhibitors >

<<Previous Next>>

Post Date:Jul-20-20

Using Genome-Editing Tools to Develop a Novel In Situ Coincidence Reporter Assay for Screening ATAD3A Transcriptional Inhibitors

AcceGenAuthor: AcceGen R&D Team

Date Published: 20-Jul-20

Using Genome-Editing Tools to Develop a Novel In Situ Coincidence Reporter Assay for Screening ATAD3A Transcriptional Inhibitors

  • Authors: Liwei Lang, Yong Teng
  • Journal: Methods Mol Biol
  • DOI: 10.1007/978-1-0716-0471-7_8
  • Cited AcceGen Product/Service:

<<Previous Next>>

AcceGen Scroll Top Button
Copy link